We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

16 hedge funds and large institutions have $1.07M invested in InVivo Therapeutics Holdings Corp in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

7% more funds holding

Funds holding: 15 → 16 (+1)

5% less capital invested

Capital invested by funds: $1.12M → $1.07M (-$54K)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$32.5K
2
Renaissance Technologies
Renaissance Technologies
New York
+$29K
3
UBS Group
UBS Group
Switzerland
+$6.96K
4
MAM
Meeder Asset Management
Ohio
+$2.32K

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$171K
2
JP Morgan Chase
JP Morgan Chase
New York
-$3.48K
3
BCM
Bridgeway Capital Management
Texas
-$2.32K
4
Morgan Stanley
Morgan Stanley
New York
-$1.16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$591K +$29K +25 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$133K – – –
CH
3
CVI Holdings
Delaware
$116K -$171K -147 -60%
ICM
4
IMS Capital Management
Oregon
$45K – – –
BCM
5
Bridgeway Capital Management
Texas
$39K -$2.32K -2 -6%
Citadel Advisors
6
Citadel Advisors
Florida
$33K +$32.5K +28 New
BlackRock
7
BlackRock
New York
$31K – – –
Northern Trust
8
Northern Trust
Illinois
$23K – – –
PWM
9
Paulson Wealth Management
Illinois
$17K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$15K – – –
Morgan Stanley
11
Morgan Stanley
New York
$7K -$1.16K -1 -14%
MAM
12
Meeder Asset Management
Ohio
$7K +$2.32K +2 +50%
UBS Group
13
UBS Group
Switzerland
$7K +$6.96K +6 New
NCM
14
Next Capital Management
New York
$2K – – –
AG
15
Advisor Group
Arizona
$1K – – –
VFA
16
Valeo Financial Advisors
Indiana
$1K – – –
BNP Paribas Financial Markets
17
BNP Paribas Financial Markets
France
$2 – – –
JP Morgan Chase
18
JP Morgan Chase
New York
– -$3.48K -3 Closed

NVIV Hedge Fund Activity: Q1 2019 in Review

16 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q1 2019, worth a combined $1.07M — down 4.8% from $1.12M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new NVIV positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $32.5K. The largest seller was CVI Holdings, cutting an estimated $171K.

  • 16 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q1 2019, up from 15 in Q4 2018.
  • Funds reported $1.07M of InVivo Therapeutics Holdings Corp stock for Q1 2019, down 4.8% quarter-over-quarter.
  • 2 funds opened new InVivo Therapeutics Holdings Corp positions in Q1 2019 and 1 closed out, a net change of +1 holder.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q1 2019 was Citadel Advisors, an estimated $32.5K added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q1 2019 was CVI Holdings, an estimated $171K sold.

Based on aggregated 13F filings for Q1 2019.